Zied Landoulsi

Strassen, LU, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

Journal: NPJ Parkinson's disease

Published: January 20, 2026

Progression of GBA1 severe and risk variants: a longitudinal mixed model analysis.

Progression of GBA1 severe and risk variants: a longitudinal mixed model analysis.

Journal: Frontiers in aging neuroscience

Published: December 19, 2025

Genome-wide association study of copy number variations in Parkinson's disease.

Genome-wide association study of copy number variations in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: August 24, 2025

Generation and characterization of 5 induced pluripotent stem cell (iPSC) lines from Parkinson's disease patients carrying GBA1 variants.

Generation and characterization of 5 induced pluripotent stem cell (iPSC) lines from Parkinson's disease patients carrying GBA1 variants.

Journal: Stem cell research

Published: July 03, 2025

Large-scale copy number variant analysis in genes linked to Parkinson´s disease.

Large-scale copy number variant analysis in genes linked to Parkinson´s disease.

Journal: NPJ Parkinson's disease

Published: April 18, 2025

Penetrance of Parkinson's disease in GBA1 carriers depends on variant severity and polygenic background.

Penetrance of Parkinson's disease in GBA1 carriers depends on variant severity and polygenic background.

Journal: NPJ Parkinson's disease

Published: January 29, 2025

Genome-wide association study of copy number variations in Parkinson's disease.

Genome-wide association study of copy number variations in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: September 04, 2024

Selective vulnerability of dopaminergic neurons in Parkinson's disease connects PRKN and differential expression of CHCHD2 and GPNMB.

Selective vulnerability of dopaminergic neurons in Parkinson's disease connects PRKN and differential expression of CHCHD2 and GPNMB.

Journal: Cell death & disease

Published: May 29, 2024

Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome.

Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome.

Journal: The journal of prevention of Alzheimer's disease

Published: May 06, 2024

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.

Journal: NPJ Parkinson's disease

Published: December 18, 2023

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease.

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 20, 2023

Genetic landscape of Parkinson's disease and related diseases in Luxembourg.

Genetic landscape of Parkinson's disease and related diseases in Luxembourg.

Journal: Frontiers in aging neuroscience

Published: August 23, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026